FILTER

Refine your search with the following facets to narrow down your results.

17 Current news of Evotec

Evotec and Dow AgroSciences announce collaboration on Cellular Target Profiling

11-Jul-2013 - Evotec AG announced that Evotec and Dow AgroSciences (DOW) have entered into a research collaboration with the objective of leveraging Evotec's chemical proteomics services to support compounds in development at Dow AgroSciences. To this end, Evotec will perform chemical proteomics services ...

Evotec proteomics

Evotec to realign Discovery Chemistry Operations

10-Jul-2013 - Evotec AG announced that it will close its Chemistry Operations in Thane, India. All chemistry efforts will now be performed at its Abingdon (UK) facility, answering to an increasing requirement to operate closer to the principal R&D laboratories of our major customers. All project work in Thane ...

Evotec India

Evotec AG announces multi-year agreement with The United States Environmental Protection Agency (EPA)

07-May-2012 - Evotec AG announced that Evotec has entered into a multi-year compound management agreement with the United States EPA. The contract covers a period of five years and has a total value of up to EUR7.7 million (approx. USD 10 million).Under the agreement Evotec, through its San Francisco ...

chemicals compound management Evotec +1

PerkinElmer Completes Acquisition of Euroscreen Products SA And Evotec Technologies

15-Jan-2007 - PerkinElmer, Inc. reported that it has successfully completed two previously announced acquisitions that will extend its portfolio of advanced tools for cellular analysis and High Content Screening (HCS). In the fourth quarter of 2006, the Company announced its intent to acquire Euroscreen ...

cellular imaging PerkinElmer solution

PerkinElmer to Acquire Evotec Technologies

04-Dec-2006 - PerkinElmer, Inc. announced that it has signed a definitive agreement with Evotec AG to acquire its majority owned subsidiary, Evotec Technologies GmbH, in a cash transaction valued at approximately EUR 23 million. The transaction is subject to regulatory approvals and other customary closing ...

biotechnology Evotec PerkinElmer +2

Procter & Gamble Selects Evotec as Provider of Pharmaceutical Discovery and Chemical Development Services

25-Jul-2005 - Evotec AG and Procter & Gamble Pharmaceuticals, Inc. (P&GP), a subsidiary of The Procter & Gamble Company announced that they have entered into agreements whereby Evotec will provide pharmaceutical discovery and chemical development services to P&GP. Under the terms of the agreements, P&GP will ...

computational chemistry Evotec medicinal chemistry +3

Biogen Idec Selects Evotec OAI as a Service Provider for Process Research & Development

19-Jul-2004 - Evotec OAI AG a leading partner for integrated, high-value-added drug discovery and development solutions, today announced that Biogen Idec has selected Evotec OAI as one of its service providers for chemical process research and development and cGMP manufacturing. The companies have expanded ...

active pharmaceutical ingredients Biogen Idec clinical trials +3

Evotec OAI and Roche enter into Strategic Global Discovery Chemistry Agreement

12-May-2004 - Evotec OAI and Roche have a long-standing relationship that includes three chemistry alliances since 2001 when Evotec OAI began supporting four Roche sites in the design and synthesis of high quality chemical compounds. These compounds were added to the Roche compound library collection and used ...

chemistry Evotec medicinal chemistry +2

Evotec OAI and Rib-X Pharmaceuticals Enter Into Medicinal Chemistry Collaboration

16-Jan-2004 - Evotec OAI AG and Rib-X Pharmaceuticals, Inc., announced the formation of a medicinal chemistry partnership. Scientists from Rib-X and Evotec OAI will collaborate on several research programmes. Evotec OAI will be utilising its state-of-the-art integrated medicinal chemistry and parallel ...

antibiotics Evotec Formation +2

Evotec OAI Signs Medicinal Chemistry Agreement with Axxima Pharmaceuticals

25-Jun-2003 - Evotec OAI, a partner for integrated high-value-added drug discovery services to the pharmaceutical and biotechnology industries, and Axxima Pharmaceuticals AG, a drug discovery and development company leading the field of pathogen-host signal transduction, today announced that they have entered ...

anti-infectives biotechnology chemistry +6